Key points are not available for this paper at this time.
This report provides Class III evidence that the NfL electrochemiluminescence immunoassay accurately distinguishes patients with sporadic ALS from healthy controls.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ching‐Hua Lu
China Medical University
Corrie Macdonald‐Wallis
NHS Blood and Transplant
Elizabeth Gray
Pfizer (United States)
Neurology
University College London
Queen Mary University of London
Building similarity graph...
Analyzing shared references across papers
Loading...
Lu et al. (Fri,) studied this question.
synapsesocial.com/papers/69d7c5ce6c394ad7d0beda8c — DOI: https://doi.org/10.1212/wnl.0000000000001642
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: